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a b s t r a c t
Human dental follicle cells (DFCs) derived from wisdom teeth are precursor cells for cementoblasts. In
this study, we recognized that naı¨ve DFCs express constitutively the early neural cell marker b-III-
tubulin. Interestingly, DFCs formed b-III-tubulin-positive neurosphere-like cell clusters (NLCCs) on low-
attachment cell culture dishes in serum-replacement medium (SRM). For a detailed examination of the
neural differentiation potential, DFCs were cultivated in different compositions of SRM containing
supplements such as N2, B27, G5 and the neural stem cell supplement. Moreover, these cell culture
media were combined with different cell culture substrates such as gelatin, laminin, poly-L-ornithine or
poly-L-lysine. After cultivation in SRM, DFCs differentiated into cells with small cell bodies and long
cellular extrusions. The expression of nestin, b-III-tubulin, neuron-specific enolase (NSE) and
neurofilament was up-regulated in SRM supplemented with G5, a cell culture supplement for glial
cells, and the neural stem cell supplement. DFCs formed NLCCs and demonstrated an increased gene
expression of neural cell markers b-III-tubulin, NSE, nestin and for small neuron markers such as
neuropeptides galanin (GAL) and tachykinin (TAC1) after cultivation on poly-L-lysine. For a further
neural differentiation NLCC-derived cells were sub-cultivated on laminin and poly-L-ornithine cell
culture substrate. After 2 weeks of differentiation, DFCs exposed neural-like cell morphology with small
neurite-like cell extrusions. These cells differentially express neurofilament and NSE, but only low levels
of b-III-tubulin and nestin. In conclusion, we demonstrated the differentiation of human DFCs into
neuron-like cells after a two-step strategy for neuronal differentiation.
& 2009 International Society of Differentiation. Published by Elsevier Ltd. All rights reserved.
1. Introduction
Although the use of human embryonic stem cells poses
multiple options for cell therapies of neural diseases, the
development of therapeutic replacement strategies using adult
stem cells remains a realistic alternative. Neural differentiation of
bone marrow-derived mesenchymal stem cells was evaluated in
various previous studies (Chen et al., 2006; Corti et al., 2004).
Here a rather wide range of chemicals, growth factors and cell
culture substrates have been used in efforts to initiate neural
differentiation of mesenchymal stem cells with varying success
(Chen et al., 2006; Corti et al., 2003; Hemptinne et al., 2004;
Hermann et al., 2004, 2006; Ho et al., 2006; Krabbe et al., 2005).
Dental stem cells are related to bone marrow-derived mesench-
ymal stem cells but they are less well characterized for neural
differentiation (Morsczeck et al., 2008). Dental cells are none-
theless easily accessible and therefore an interesting alternative
for cell therapy approaches (Morsczeck et al., 2008). Shi and
coworkers isolated SHED (stem cells from human exfoliated
deciduous teeth) that can differentiate into a variety of cell types,
including neural cells (Miura et al., 2003). Recently, neural stem
cells could be isolated from dental tissues, which could be
propagated as neurospheres under serum-free medium conditions
supplemented with growth factors (Widera et al., 2007). Today,
the formation of neurospheres is the most common way of
isolating and expanding neural stem cells in vitro (Campos, 2004).
Isolated periodontal stem cells were highly proliferative (Widera
et al., 2007). Growth factor deprivation and retinoic acid
treatment led to the acquisition of neural morphology and stable
expression of markers of neural differentiation by more than 90%
of the cells (Widera et al., 2007). In contrast to these periodontal-
derived neural stem cells, dental pulp-derived stem cells or dental
follicle cells (DFCs) are – like bone marrow-derived mesenchymal
stem cells – plastic-adherent cells.
In our study we investigated neural differentiation potential of
dental follicle cells, which were isolated from the ectomesenchymal
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dental follicle (Morsczeck, 2006; Morsczeck et al., 2005a, b).
Ectomesenchymal cells are derived from the neural crest, which
also give rise to the peripheral nervous system (Pardal et al., 2007).
In this context, Pardal et al. (2007) recently discovered neural crest
stem cells of the peripheral nervous system, which generated
dopaminergic neurons in vivo. This fact makes very promising the
use of ectomesenchymal cells for neural tissue cell therapies. In
previous studies, we demonstrated that DFCs can differentiate into
osteogenic cells under in vitro and in vivo conditions (Morsczeck
et al., 2005a, b). Recently, Kemoun et al. (2007) demonstrated that
isolated dental follicle cells expressed the mesenchymal stem cell
marker STRO-1. Moreover, they confirmed that follicle cells have
multipotential mesenchymal precursor cell properties after differ-
entiating toward multiple mesenchymal-derived cell types, such as
cementoblasts, chondrocytes and adipocytes (Kemoun et al., 2007).
However, they did not demonstrate neural cell differentiation
potential for dental follicle cells.
The neural differentiation potential of DFCs under in vitro
conditions was therefore evaluated for the first time. In this study,
various cell culture media conditions were examined and
compared in combination with different surface modifications
for neurosphere-like cell cluster (NLCC) formation in DFCs. We
investigated furthermore the expression of neural cell-specific cell
markers in DFCs by immunocytochemistry and quantitative real-
time RT-PCR. For a further neural differentiation, NLCCs were
cultivated on poly-L-ornithine and laminin.
2. Materials and methods
2.1. Cell culture
Normal human impacted third molars were collected from
adults (18 and 24 years). Coronal parts of the dental follicle were
derived from unerupted or partially erupted wisdom teeth. The
surfaces of these tissues were cleaned and minced by using a
sterilized scalpel. Dental follicle precursor cells were isolated as
described previously (Kemoun et al., 2007; Morsczeck et al.,
2005a, b). Dental follicle precursor cells were seeded into cell
culture flasks in regular cell culture medium DMEM [Dubelco
modified Eagle medium (with L-glutamine) supplemented with
10% fetal calf serum and penicillin/streptomycin (all purchased
from PAA, Pasching, Austria] and incubated at 37 1C in 5% CO2 in a
humidified atmosphere.
For the induction of neural differentiation, various cell culture
media were used. DFCs were used at passage 5 for experiments.
Cell culture media were based on serum-replacement media
(SRM) comprising Neurobasal medium (PAA) containing different
supplements and growth factors. We tested different neural stem
cell differentiation media (NSCM) protocols in our study. These
protocols were combined with different cell substrates (see
below). For neural differentiation protocol NSCM I DFCs were
cultured in Neurobasal medium containing L-glutamine, the
G5-supplement and neural stem cell supplement (all PAA) for
one week. The G5 supplement contains 100mg/ml biotin, 1mg/ml
EGF, 500ng/ml FGF-2, 500mg/ml human transferrin, 360ng/ml
hydrocortisone, 500mg/ml insulin, 520ng/ml sodium selenite.
For protocol NSCM II DFCs were cultivated in the Neurobasal
medium containing L-glutamine, the B27 supplement (all PAA) in
combination with growth factors (20ng/ml EGF (Sigma-Aldrich,
St. Louis, USA) and 20ng/ml FGF-2 (Sigma-Aldrich)) for 4 days and
without growth factors but with retinoic acid for additional
7 days. The B27 supplement were purchased from PAA and
contains undisclosed concentrations of biotin, L-carnitine, choles-
terol, corticosterone, ethanolamine, D(+)-galactose, glutathione
(reduced), lecithin, linoleic acid, linolenic acid, phosphatidylcholin,
progesterone, putrescine, retinol, retinyl acetate, sodium selenite,
T3 (triodo-I-thyronine), DL-a-tocopherol (vitamin E), DL-a-toco-
pherol acetate, albumin, catalase, insulin, superoxide dismutase,
and transferring. For NSCM III, cells were cultivated in Neurobasal
medium supplemented with B27 and retinoic acid without
growth factors for 7 days. DFCs were plated at a cell density of
25,000 cells/cm2 for neural differentiation. Cell culture media
were changed every second day.
For further neural differentiation, cells were incubated as
follows. DFCs were cultivated in NSCM I on poly L-lysine to form
neurosphere-like structures. These pre-differentiated DFCs were
further differentiated by protocol NDSS: DMEM/F12 Media (PAA),
Insulin–transferrin–sodium selenite supplement (ITTS, Roche,
Mannheim, Germany), 100U/ml penicillin and 100mg/ml strepto-
mycin, and 40ng/ml FGF-2 for 14 days. The medium was
supplemented with 0.5mM retinoic acid (Sigma-Aldrich) between
days 7 and 14 of differentiation. The surface was modified with
poly-L-ornithine and laminin.
2.2. Preparation of culture substrates
The expansion and induction of neural differentiation
under different cell culture conditions were performed in 6-well
tissue grade polystyrene plates. The surfaces of wells were
precoated with substrates of interest. The following concentra-
tions were applied for surface modifications: gelatin (0.2mg/cm2),
poly-L-lysine (2mg/cm2), laminin (5mg/cm2), poly-L-ornithine
(10mg/cm2) or fibronectin (2mg/cm2). Substrates were purchased
from Sigma-Aldrich and BD Biosciences (Heidelberg, Germany).
2.3. Immunocytochemistry
Fixed cells were washed in Tris-buffered saline (BS) (0.15M
NaCl, 0.1M Tris–HCl, pH 7.5), then blocked with a solution
composed of TBS, 0.1% Triton-X100 (only for intracellular
antigens), 1% bovine serum albumin (BSA) and 0.2% Teleostean
gelatin (Sigma-Aldrich) (fish gelatin buffer [FGB]). The same
solution was used during the incubations with antibodies.
Primary antibodies were applied overnight at 4 1C. Fluoro-
chrome-conjugated species-specific secondary antibodies were
used for immunodetection.
The following antibodies and final dilutions were used.
Primary antibodies: mouse anti-neuron-specific enolase (anti-
NSE) (1:200; AbD serotec); rabbit anti-glial fibrillary acidic
protein (GFAP) (1:1,000; Dako Denmark A/S, Glostrup); mouse
anti-rat nestin (1:500; BD PharMingen, San Diego, USA); mouse
anti-Map 2a+2b (1:250; Sigma-Aldrich); mouse anti-b-III-tubulin
(1:500; clone 5G8; Promega, Madison, USA); mouse anti-(PAN)
neurofilament medium and heavy (1:1000 Invitrogen, Karlsruhe,
Germany); secondary antibodies: donkey anti-goat, -mouse, -
rabbit or -rat conjugated with Alexa Fluor 488 (Invitrogen), goat
anti-mouse, -rabbit or -rat conjugated with Alexa Fluor 488,
RHOX (1:500). Nuclear counterstaining was performed with
40,60-diamidino-2-phenylindole dihydrochloride hydrate (DAPI)
at 0.25mg/ml (Sigma-Aldrich). Specimens were mounted on
microscope slides using a Prolong Antifade kit (Invitrogen).
Epifluorescence observation and photodocumentation were
accomplished using a Leica microscope. For negative controls,
the primary antibodies were omitted.
2.4. Real-time reverse transcription (RT)-PCR
Total RNA was isolated from cells with the RNeasy Kit (Qiagen,
Hilden, Germany). Genomic DNA contamination was eliminated
with Rnase-free DNase for on-column digestion (Macherey-Nagel,
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Du¨ren, Germany). Total RNA from human total brain was derived
from Clontech (Mountain View, USA). First-strand cDNA synthesis
was performed by using 0.4mg total RNA and the First Strand
cDNA Synthesis Kit (Fermentas, St. Leon-Rot, Germany). We used
the TaqMans Fast Universal PCR Master Mix (Applied Biosystems,
Foster City, USA). Sequences for primers and probes were selected
using the Universal ProbeLibrary Assay Design Center (www.
roche-applied-science.com) and can be obtained from the
authors. For quantification, we used the delta/delta calculation
method described previously (Winer et al., 1999). The house-
keeping genes for GAPDH and GUS were used as reference genes
in all applications. PCR primers were established with total RNA
from the brain (Clontech, Mountain View, USA). For negative
control the reverse transcriptase omitted in the first-strand
synthesis kit (-RT, data not shown). PCR primers were established
by using cDNAs made from commercial available total RNA from
various human tissues (BD Bioscience, Franklin Lakes, NJ, USA).
3. Results
3.1. Gene expression of neural cell markers in naı¨ve DFCs
DFCs were isolated and initially cultivated in regular cell
culture medium. The growth curve demonstrated cell prolifera-
tion of DFCs at passage 6 (Fig. 1). Before evaluation of neural cell
differentiation, the expression of neural cell markers was
investigated in naı¨ve DFCs by immunocytochemistry. These cells
express not only the neural progenitor cell marker nestin as
previously described (Morsczeck et al., 2005a, b) but also neural
cell makers, which represent different developmental stages. In
immunocytochemical stainings, DFCs expressed the early neural
cell marker b-III-tubulin (94%74.7 SEM), but late neural
differentiation markers such as neurofilament and NSE were
weakly expressed if at all (Fig. 2A). However, the glial cell marker
GFAP was not detected in undifferentiated cells (data not shown).
Interestingly, DFCs formed nestin and b-III-tubulin-positive
neurosphere-like cell clusters after cultivation on low-
attachment cell culture dishes. Here, cells were cultivated in
serum-free cell culture medium containing the B27 supplement
and EGF and FGF-2 (Fig. 2B). The gene expression of neurofilament
and b-III-tubulin was up-regulated in NLCCs (Fig. 2C).
3.2. Pre-differentiation of DFCs (first step)
For a detailed analysis of the neural differentiation of DFCs we
examined cell morphology, NLCC formation and gene expression
of neural cell markers after applying different cell culture
conditions (Figs. 3 and 4). DFCs cultivated in regular cell culture
medium (DMEM) expressed transcripts of nestin, b-III-tubulin,
neurofilament, neuron-specific enolase and MAP-2 at all points in
time of the study. DMEM-treated DFCs demonstrated a
fibroblastic cell morphology on all tested cell culture surfaces
(Fig. 3) and neural cell markers were almost constitutively
expressed on all different surface modifications (Fig. 4).
However, gene expression of nestin was up-regulated on poly-L-
lysine (Fig. 4). In contrast, the expression of neural cell markers
was up-regulated in SRM; especially after cultivation in NSCM I
(Fig. 4F). Cell morphologies of DFCs in SRM varied with different
substrate surface modifications. DFCs formed NLCCs on poly-L-
lysine with each tested combination of SRM. Most of dental
follicle cell-derived NLCCs had a diameter of about 50–150mm
(Fig. 5). In contrast to poly-L-lysine we detected only surface
adherent cells on gelatin and laminin. Here, cells displayed
relatively long axon-like cell extensions (Fig. 3). On laminin/
poly-L-ornithine, DFCs differentiated into surface adherent cells in
NSCM I and NSCM III (Fig. 3) and formed adherent NLCCs after 4
days and free-floating NLCCs after additional 7 days of treatment
with NSCM II protocol (Fig. 3). However, neural cell markers
nestin and b-III-tubulin were constitutively expressed in NSCM II
and NSCM III but differentially expressed in NSCM I (Fig. 4).
Interestingly, gene expression of NSE was differentially expressed
in cells after the formation of NLCCs on poly-L-lysine and in NSCM
II on laminin/poly-L-ornithine. For an evaluation of real-time
RT-PCR data, a statistical test (multiple ANOVA, analysis of
variance) was done. The dependence of neural cell marker
expression on cell culture media and cell culture substrate
demonstrated a peak neural differentiation on poly-L-lysine
surface with use of cell culture medium NSCM I and high
expression levels of NSE in NSCM II and NSCM III (Fig. 4).
We made a real-time RT-PCR analysis (Table 1) for marker
genes of neural subpopulations for a further categorization of
differentiated cells (Lemke et al., 1997; Martinez-Gutierrez and
Castellanos, 2007). The expression of choline acetyltransferase
characteristically for cholinergic neurons was detected neither
before nor after differentiation of DFCs (data not shown).
Calretinin (CALB2), a calcium-binding protein involved in
calcium signaling, is often expressed in GABAergic neural
cells. DFCs expressed CALB2 at all timepoints, but were not
differentially affected by culture conditions (Table 1). Parvalbumin
(PVALB) is present in GABAergic interneurons of the nervous
system and was expressed after cultivation in DMEM on poly-L-
lysine and after differentiation in NSCM II on laminin, but not
expressed in naı¨ve DFCs on polysterene. The neuropeptides
galanin (GAL) and tachykinin (TAC1), the precursor of substance
P, are small or small/intermediate neuron markers. DFCs in DMEM
and polysterene expressed GAL and TAC1 at low levels. Gene
expression of both markers was increased after differentiation
in SRM, especially in NLCCs on poly-L-lysine and on laminin/poly-
L-ornithine (Table 1). Therefore NLCCs probably contain small-
and intermediate-sized neurons or neural precursor cells.
Interestingly, the large neuron marker vasoactive intestinal
peptide (VIP) was also expressed weakly after differentiation
with NSCM I and NSCM II (Table 1). We found that tyrosine
hydoxylase (TH), a marker of dopaminergic neurons, was
detectable only in DFCs after cultivation in NSCM II and NSCM
III on polysterene. However, this marker was expressed after
cultivation on poly-L-lysine and gelatin. Glutamate decarboxylase
1 (GAD1), a marker of GABAergic neurons, was down-regulated or
not differentially expressed after differentiation. In contrast, the
gene of the neurotransmitter transporter serotonin (SLC6A4), a
marker of serotonergic neurons, was differentially expressed after
cultivation in SRM.
ARTICLE IN PRESS
Fig. 1. Growth curve of DFCs. Cells were plated at a density of 5000 cells/cm2 and
cultured in serum-containing regular cell culture medium for 6 days. Cells were
harvested each day and counted with a hemocytometer. Values expressed are the
mean7SEM.
F. Vo¨llner et al. / Differentiation 77 (2009) 433–441 435
Author's personal copy
3.3. Neural differentiation of pre-differentiated DFCs (second step)
To achieve more advanced neural differentiation we produced
NLCCs in NSCM I and differentiated these cells with a protocol
that was recently described for neural differentiation of dental
pulp stem cells (Arthur et al., 2008). After cultivation on poly-L-
ornithine and laminin NLCCs attached, spread and formed single
cells with neuron-like morphologies (Fig. 6E–H). These cells
differentially expressed neuron cell markers such as neuron-
specific enolase and neurofilament, which were weakly expressed
in undifferentiated DFCs (Fig. 6A–D). In contrast, early neural
cell markers, nestin and b-III-tubulin, which were strongly
expressed in naı¨ve DFCs, were down-regulated after the second
differentiation step. We detected by real-time RT-PCRs that gene
expression of nestin, increased after the formation of NLCCs, and
was down-regulated after a further differentiation step. Moreover,
the early neuron-specific marker b-III-tubulin was constitutively
expressed after the second step of differentiation. In contrast,
gene expression of NSE and neurofilament was increased
after differentiation (Fig. 6I). Here, gene expression of NSE
was remarkably increased after the second differentiation step
on poly-L-ornithine and laminin. Gene markers for neural
subpopulations demonstrated a differential expression of
the neuropeptide TAC1 and the calcium-binding protein
CALB2 (Fig. 6J). By contrast, expression levels of SLC6A4, GAD1
and GAL were lower than in undifferentiated or pre-differentiated
DFCs. All other tested marker genes of neural subpopulations
were not expressed in differentiated DFCs. The astrocyte marker
GFAP was not detected before and after differentiation (data not
shown).
4. Discussions
DFCs can differentiate into various cell types like cemento-
blasts, adipocytes or chondrocytes. However, less was known
about neural differentiation potential of DFCs (Kemoun et al.,
2007; Morsczeck et al., 2005a, b). In our study naı¨ve DFCs strongly
expressed early neural cell markers and on a low level markers for
mature neural cells (Campos, 2004; Corti et al., 2003; Wachs et al.,
2003; Widera et al., 2007). The expression of cell markers can be
identified in naı¨ve DFCs by both immunocytochemistry and
quantitative (real-time) RT-PCR. The real-time RT-PCR is the most
sensitive technique for a quantitative analysis of gene expression
(Peirson et al., 2003). In our study, we were interested in also
recording minor effects on neural differentiation after applying
different cell culture conditions. Gene expression profiles of
neural cell markers were therefore estimated by real-time
RT-PCR after neural differentiation.
This study characterized human dental follicle cells after
cultivation in three different SRMs, which comprise the B27
supplement or the G5 supplement for maintenance and differ-
entiation of neural stem cells (Wachs et al., 2003). The B27
supplement was frequently used for neural stem cell cultures
and for neural differentiation of somatic stem cells (Engelhardt
et al., 2004, 2005; Miura et al., 2003; Wachs et al., 2003; Widera
et al., 2007). NSCM II was a two-step neural differen-
tiation protocol adapted from a successful protocol for neural
differentiation of mesenchymal stem cells (Hermann et al.,
2004, 2006). Here, Storch and colleagues were able to trans-
differentiate human mesenchymal stem cells into NLCCs and
later into neural-like cells. In our study the formation of NLCCs
was evident with NSCM II (day 11) in combination with the
cell culture substrate laminin/poly-L-ornithine, but only the
expression of NSE does support this tendency of neural differ-
entiation. However, we also made use of a less-often utilized
serum-free medium (NSCM I) composed of the G5-supplement
and a specific neural stem cell supplement. The G5-supple-
ment was originally designed for cell-growth and differentia-
tion of glial cells and contains growth factors such as EGF and
FGF (Michler-Stuke and Bottenstein, 1982). Recently, it was also
used for neural differentiation of mesenchymal stem cells
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Fig. 2. Analysis of neural differentiation of DFCs on low attachment cell culture dishes. (A) Immunofluorescence study for the expression of neural cell marker b-III tubulin
(TUBB3), neuron-specific enolase (NSE), PANneurofilament and neuronal progenitor cell marker nestin (NES) in naı¨ve DFCs. Antibody staining was applied as described
under Section 2. For negative control the primary antibody was omitted (negative control). (B) Cells were cultivated in Neurobasal medium containing the B27 supplement
in combination with EGF and FGF-2. Here, DFCs formed nestin and b-III-tubulin-positive NLCCs. For negative controls the primary antibody was omitted. (C) Gene
expression of neurofilament (NEFH), b-III-tubulin (TUBB3) and nestin (NES) in DFCs before (undifferentiated) and after the formation of NLCCs (differentiated); determined
by real-time RT-PCR. Total RNA from naı¨ve DFCs before differentiation was used for calibration (relative gene expression ¼ 1).
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(Hemptinne et al., 2004). Interestingly, in our study this medium
was the most favorable for a pre-differentiation of DFCs into
neural precursor cells.
For our study surface modifications were used that previously
facilitated neural differentiation of stem cells. Gelatin-coated
wells, for example, were successfully used for neural and glial cell
differentiation of embryonic stem cell-derived neural progenitor
cells (Goetz et al., 2006; Zhang et al., 2006). In this study, gelatin
does not improve neural differentiation of DFCs. For the
differentiation of neural stem cells, cell culture dishes were often
modified with laminin or a combination of laminin and poly-
ornithine or poly-D-lysine (Engelhardt et al., 2004, 2005; Ho et al.,
2006; Widera et al., 2007). We identified (as mentioned above)
the formation of NLCCs from DFCs after cultivation on laminin/
poly-L-ornithine in combination with NSCM II. For mesenchymal
stem cells, Ho et al. (2006) demonstrated that the induction of the
neural stem cell marker, nestin, depends on a laminin substrate. In
contrast, Storch and colleagues described the expression of nestin
in naı¨ve mesenchymal stem cells (Hermann et al., 2004; Hermann
et al., 2006). These experiments suggest that the expression of
neural cell markers is also strongly dependent on cell isolation
procedures and the quality of donor tissues. For neural differ-
entiation Storch and colleagues successfully applied poly-L-lysine
for the neural differentiation of mesenchymal stem cells
(Hermann et al., 2004, 2006). In correspondence to this examina-
tion we found that poly-L-lysine is the most favorable surface
modification for the formation of NLCCs and an increased
expression of neural cell markers, especially early markers such
as b-III-tubulin. In this context, it is remarkable that the
expression of the neural progenitor cell marker, nestin, was
significantly up-regulated (po0.05; n ¼ 3; Student’s t-test, statis-
tics not shown in Fig. 4) after cultivation on poly-L-lysine in
regular cell culture medium in comparison to each other tested
cell culture surface. Interestingly the formation of NLCCs and the
up-regulation of the neural cell marker NSE correlate very well in
this study.
To obtain differentiated DFCs with typical neural cell morphol-
ogy a second step of neural differentiation was required. In
contrast to naı¨ve DFCs, these cells strongly express neurofilament.
However, neural differentiation of DFCs was not possible without
a pre-differentiation step. Neural differentiated DFCs differentially
express the neuropeptide, TAC1, which is thought to function
as a neurotransmitter which interacts with nerve receptors
and smooth muscle cells. Interestingly, TAC1 was also identified
in neural differentiated mesenchymal stem cells (Cho et al.,
2005).
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Fig. 3. Light microscope images displaying DFCs after cultivation in SRM. Cells were cultivated in regular cell culture media with serum (DMEM), NSCM I and NSCM III for 7
days on different surface modifications. For cultivation in NSCM II DFCs were pre-differentiated in Neurobasal-medium with B27 supplement, 20 ng/ml EGF and 20ng/ml
FGF-2 without retinoic acid for 4 days (NSCM II day 4). Here, cells formed surface adherent NLCCs. These pre-treated DFCs were then cultivated without growth factors but
with retinoic acid for additional 7 days (NSCM II day 11). DFCs formed NLCCs on poly-L-lysine in NSCM I, NSCM II and NSCM III and on poly-L-ornithine/laminin in NSCM II.
DFCs were surface adherent and had fibroblastic cell morphology in DMEM. In contrast to DMEM single DFCs became neural-like cells after cultivation in NSCM I, NSCM II
and NSCM III on gelatin, laminin and polystyrene. Similar morphologies were observed on laminin/poly-L-ornithine in NSCM I and NSCM III.
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Our study investigated neural differentiation of human
DFCs for the first time. We demonstrated that naı¨ve DFCs express
early neural cell markers. In our study, naı¨ve and differentiated
DFCs did not express the glial cell marker GFAP. We conclude
that DFCs are neural precursor without potential for glial cell
differentiation. Further investigation will determine whether
the expression of glial cell markers depends on appropriate cell
culture conditions. DFCs differentiate into cells at an early
stage of neural differentiation that was demonstrated by an up-
regulation of early neural cell markers and by the formation of
NLCCs. After a second step of differentiation, late neural cell
markers, NSE and neurofilament were up-regulated. We conclude
that DFCs displayed characteristics of neural progenitor cells
and they are a promising alternative for new cell therapy
approaches.
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Fig. 4. Real-time RT-PCR analysis for relative gene expression of neural cell markers in DFCs after cultivation in SRM on different cell culture substrates: Real-time RT-PCR
results (A–E). Columns of each diagram represent the average of three biological replicates (n ¼ 3). Total RNA from naı¨ve DFCs before differentiation were used for
calibration (relative gene expression ¼ 1). PCRs were done in duplicates for each sample (F and G). For the evaluation of neural cell marker expression dependent on cell
culture medium (medium) and cell culture substrate (surface) f-values were calculated by multivariate analysis of variance (MANOVA). An up-regulation of neural cell
markers were detectable for DFCs cultivated in NSCM I (nestin, b-III tubulin, neurofilament) and on poly-L-lysine (b-III-tubulin, nestin). Abbreviations: PS: polysterene;
lysine: poly-L-lysine; orn/lam: poly-L-ornithine/laminin.
Fig. 5. Assessment of the neurosphere-like cell cluster (NLCCs) size of DFCs after
differentiation with NSCM I on poly-L-lysine. For this test 250,000 cells were
seeded and NLCCs were counted and sizes were measured after differentiation
(average7SEM; n ¼ 3).
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Table 1
Real-time RT-PCR assay with specific primers for markers of neural subpopulations after cultivation in SRM on different cell culture substrates.
DMEM NSCM I
Dopaminergic Serotonergic GABAminergic Neuropeptide Ca-binding system Dopaminergic Serotonergic GABAminergic Neuropeptide Ca-binding system
TH SLC6A4 GAD1 GAL TAC1 VIP PVALB CALB2 TH SLC6A4 GAD1 GAL TAC1 VIP PVALB CALB2
Polystyrene n. d. 0.640 0.275 0.673 0.417 n. d. n. d. 0.227 n. d. 0.877 0.174 0.114 0.759 n. d. n. d. 0.071
Gelatine + 1.405 0.459 0.664 1.043 n. d. n. d. 0.741 n. d. 2.353 0.359 0.488 4.105 + n. d. 0.167
Poly-L-lysine + 1.212 0.206 1.532 1.774 n. d. + 0.750 + 3.121 0.113 9.779 5.359 + n. d. 0.205
Laminin n. d. 0.383 0.207 0.296 0.830 n. d. n. d. 0.324 n. d. 1.137 0.181 0.261 1.582 + n. d. 0.134
Ornitine/laminin n. d. 0.209 0.069 0.333 0.481 n. d. + 0.140 n. d. 0.554 0.077 0.267 2.124 n. d. n. d. 0.116
NSCM II NSCM III
Dopaminergic Serotonergic GABAminergic Neuropeptide Ca binding system Dopaminergic Serotonergic GABAminergic Neuropeptide Ca binding system
TH SLC6A4 GAD1 GAL TAC1 VIP PVALB CALB2 TH SLC6A4 GAD1 GAL TAC1 VIP PVALB CALB2
Polystyrene + 3.056 0.114 4.536 3.428 + n. d. 0.181 + 5.909 0.484 4.932 5.793 + n. d. 0.361
Gelatine + 5.247 0.234 0.762 3.478 + n. d. 0.112 + 6.960 0.371 0.925 2.172 + n. d. 0.156
Poly-L-lysine + 1.123 0.186 12.023 5.805 + n. d. 0.421 + 4.153 1.028 68.872 2.909 n. d. n. d. 1.523
Laminin + 3.942 0.149 2.729 6.397 + + 0.129 + 2.038 0.094 1.629 3.091 + n. d. 0.098
Ornitine/laminin + 0.763 0.065 17.068 2.617 n. d. + 0.229 n. d. 1.241 0.059 1.583 2.214 + n. d. 0.085
Relative gene expression is displayed for marker genes of neuropeptide, GABAergic, dopaminergic or serotonergic neurons (for details text). Total RNA isolated from naı¨ve DFCs were used for calibration (relative gene
expression ¼ 1). Numbers represent the average of three biological replicates (n ¼ 3). Marker gene expression identified differentiated cells only were marked with ‘‘+’’. Abbreviations: n.d.: not detected, PVALB: parvalbumin,
CALB2: calbindin 2, GAL: galanin, TAC1: tachykinin, TH: tyrosine hydoxylase, SLC6A4: neurotransmitter transporter serotonin, GAD1: glutamate decarboxylase 1, VIP: vasoactive intestinal peptide.
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Zusammenfassung 
 
In der modernen Medizin ist der Einsatz von Stammzellen zunehmend unverzichtbar. So er-
möglicht das Tissue Engineering durch die Kombination autolog gewonnener Zellen und bio-
kompatibler Trägermaterialien heute bereits die Herstellung künstlicher Gewebe. Diese kön-
nen als zur Unterstützung oder Substitution von degenerierten Geweben oder Organen in den 
Patienten replantiert werden (1,2). Dentale Follikelzellen (dental follicle cells, DFCs) stellen 
hierzu eine leicht zugängliche Stammzellquelle dar. Es handelt sich um adulte Stammzellen, 
die aus dem Zahnsäckchen von Weisheitszähnen ohne abgeschlossenes Wurzelwachstum ge-
wonnen werden können und ektomesenchymalen Ursprungs sind (3). Unter in-vitro-
Bedingungen sind DFCs plastikadhärent und besitzen klonogene Eigenschaften. Sie konnten 
bereits zu Osteoblasten, Chondrozyten und Adipozyten, sowie in Zementoblasten und paro-
dontale Ligamentzellen differenziert werden. DFCs exprimieren mesenchymale Stammzel-
lenmarker wie zum Beispiel STRO-1, ein Marker für multipotente Stammzellen, aber auch 
neuronale Progenitorzellmarker wie Notch-1 und Nestin (4-6). Dies lässt auf ihre Herkunft 
von Zellen aus der Neuralleiste schließen, aus der auch das periphere Nervensystem entsteht 
(7). Allerdings konnte bislang nicht gezeigt werden, ob humane DFCs in neurale Zellen diffe-
renziert werden können. 
 
Ziel dieser Arbeit war es, das neuronale Differenzierungspotential der humanen dentalen Fol-
likelzellen zu untersuchen. Hierzu wurden die DFCs in einem ersten Schritt in drei verschie-
denen serumfreien, neuronalen Differenzierungsmedien (neuronal stem cell media, NSCM I-
III) auf unterschiedlich beschichteten Zellkulturoberflächen (Polystyrol, Gelatine, Ornithin 
oder Laminin) kultiviert. Nach einer Kultivierungszeit von 7-14 Tagen wurden die Zellen 
lichtmikroskopisch und mittels quantitativer realtime RT-PCR charakterisiert. Interessanter-
weise lösten sich die DFCs auf den mit Poly-L-Lysin und L-Ornithin beschichteten Oberflä-
chen in Kombination mit den unterschiedlichen Differenzierungsmedien von der Oberfläche 
ab und bildeten im Medium schwimmende Zellkonglomerate (neurosphere like cell cluster, 
NLCC). Es ist bekannt, dass neurospheres, die aus Zellen des zentralen Nervensystem ge-
wonnen werden, ein besonders hohes neuronales Differenzierungspotential besitzen (8). In 
der quantitativen realtime RT-PCR zeigten die NLCCs der DFCs besonders auf Poly-L-Lysin 
und dem NSCM I (Neurobasalmedium mit G5 supplement) einen Anstieg der Genexpression 
sowohl des neuralen Progenitorzellenmarkers Nestin (NES), als auch des neuronalen Zellmar-
kers β-III-Tubulin (TUBB3). β-III Tubulin zählt zu den neuronenspezifischen Markern und ist 
in frühen Stadien der neuronalen Differenzierung zu finden. Marker von späten Stadien, wie 
zum Beispiel das Neurofilament, die neuronenspezifischen Enolase (NSE) oder das „Mikro-
tubuli assoziierten Protein 2“ (MAP 2) zeigten einen nur schwachen Anstieg der Expression 
gegenüber undifferenzierten Follikelzellen. 
Zur weiteren neuronalen Differenzierung wurden die NLCCs der Paarung Poly-L-Lysin und 
dem NSCM I (Neurobasalmedium mit G5 supplement) isoliert, separiert und auf einer Lami-
nin/Poly-L-Ornithin-modifizierten Oberfläche und einem weiteren Differenzierungsmedium 
(DMEM/F12 mit Insulin–transferrin–sodium selenite supplement und FGF-2) für weitere 14 
Tage kultiviert. Die erhaltenen Zellen waren plastikadhärent und zeigten unter dem Lichtmik-
roskop eine Nervenzell-ähnliche Morphologie mit einem kleinen Zellkörper und langen 
Zellausläufern. In der quantitativen realtime RT-PCR Untersuchung und in der immunzyto-
chemischen Untersuchung exprimierten diese Zellen neben Neurofilament vor allem NSE, 
also Marker der späten neuronalen Differenzierung. Die Marker der frühen Stadien einer neu-
ronalen Differenzierung wie Nestin und β-III-Tubulin hingegen wurden stark herunterregu-
liert. 
In einer Subpopulationsanalyse zur Spezifizierung der differnzierten Zellen (9,10) zeigte sich 
ein differentieller Anstieg der Expression für die Neuropeptide Tachykinin (TAC 1) und Ga-
lanin. Tachykinin ist die Vorstufe zu der Substanz P und dient als Neurotransmitter zwischen 
peripheren Nervenzellen und der glatten Muskulatur. Interessanterweise wurde es auch bei 
neuronal differenzierten mesenchymalen Zellen gefunden (11). Galanin ist ebenfalls ein Pep-
tid, welches in vielen unterschiedlichen Neuronen exprimiert wird und unter anderem die 
Neurogenese initiiert (12). Marker dopaminerger, serotonerger oder GABAminerger Neuro-
nen konnten nicht nachgewiesen werden. 
 
Zusammenfassend konnte in dieser Arbeit ein neuronales Differenzierungspotential humaner 
dentaler Follikelzellen mittels einer Zwei-Schritt-Strategie nachgewiesen werden. Es konnte 
gezeigt werden, dass sich in einem ersten Schritt aus naїven DFCs durch eine Modifikation 
der Oberfläche und des Mediums neurosphere like cluster bilden und Marker früher Stadien 
der neuronalen Differenzierung exprimieren. Weiter konnte gezeigt werden, dass sich aus 
diesen NLCCs nach einem weiteren Differenzierungsschritt Neuronen-ähnliche Zellen bilden, 
die späte neuronale Marker wie NSE und Neurofilament exprimieren. DFCs haben ein neuro-
nales Potential und stellen somit eine vielversprechende Quelle für neue Therapieformen dar. 
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